SentiARportfolio

SentiAR is a cultivate(MD) portfolio company

cultivate(MD) Capital Funds Portfolio Company SentiAR Announces Second FDA Clearance for CommandEP™ Interface

Grand Rapids, Mich., October 23, 2023 — cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage medical device companies with innovative technologies, announced today that one of their portfolio companies, St. Louis, Missouri-based SentiAR, Inc., a pioneer in using Augmented Reality (AR) visualization technology for cardiac ablation procedures, has received their second […]

cultivate(MD) Capital Funds Portfolio Company SentiAR Announces Second FDA Clearance for CommandEP™ Interface Read More »

SentiAR is a cultivate(MD) portfolio company

SentiAR Announces Close of $8.5 million Series B Financing

Expand Partnerships and Clinical Deployments St. Louis, Missouri, April 11th, 2023 — SentiAR, Inc. a St. Louis, Missouri based pioneer in using Augmented Reality (AR) visualization technology for medical procedures, has closed an $8.5 million Series B financing. The financing was led by cultivate (MD) Ventures and joined by MedVenture Partners alongside several insider investors,

SentiAR Announces Close of $8.5 million Series B Financing Read More »